VRAY - Monster Drop. Can It Retrace The Losses?

16 авг. 2019 г.

ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

P/E Current
-4.03

P/E Ratio (with extraordinary items)
-3.37

SHORT INTEREST
22.51M 07/31/19

Average Recommendation: BUY

Average Target Price: 6.80